Lapiz, Gemilyn B.
HRN: 21-51-55 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
05/03/2025
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
05/03/2025
05/20/2025
IV
500mg
Q8
T/c Acute Appendicitis
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominalProphylaxis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes